Last updated 9 days ago

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

435 patients around the world
Available in Puerto Rico, Argentina
Acquired from Horizon in 2024.
Amgen
2Research sites
435Patients around the world
This study is for people with
Rare diseases
Sjogren's syndrome
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Consultorios Médicos Dr. Doreski
Recruiting
Av. Cabildo, Cdad. Autónoma de Buenos Aires, Argentina
GCM Medical Group
Recruiting
San Juan, 00917
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy